Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Placebo-controlled Study of Clenbuterol in Spinal and Bulbar Muscular Atrophy (SBMA)
2024-516563-86-00Phase 2Authorised
- Sponsor
- Azienda Ospedaliero-Universitaria di Padova
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in spinal and bulbar muscular atrophy (SBMA) comparing Monores (clenbuterol) arm with Placebo arm (2 arms). Planned start Sep 2024; status: authorised.
02
Drugs
clenbuterol
03
Conditions
spinal and bulbar muscular atrophy (SBMA)
Beyond the preview
Go deeper on 2024-516563-86-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-516563-86-00.